RT Journal Article
SR Electronic
T1 Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort
JF Thorax
JO Thorax
FD BMJ Publishing Group Ltd and British Thoracic Society
SP 399
OP 401
DO 10.1136/thoraxjnl-2020-216086
VO 76
IS 4
A1 Arnold, David T
A1 Hamilton, Fergus W
A1 Milne, Alice
A1 Morley, Anna J
A1 Viner, Jason
A1 Attwood, Marie
A1 Noel, Alan
A1 Gunning, Samuel
A1 Hatrick, Jessica
A1 Hamilton, Sassa
A1 Elvers, Karen T
A1 Hyams, Catherine
A1 Bibby, Anna
A1 Moran, Ed
A1 Adamali, Huzaifa I
A1 Dodd, James William
A1 Maskell, Nicholas A
A1 Barratt, Shaney L
YR 2021
UL http://thorax.bmj.com/content/76/4/399.abstract
AB The longer-term consequences of SARS-CoV-2 infection are uncertain. Consecutive patients hospitalised with COVID-19 were prospectively recruited to this observational study (n=163). At 8–12 weeks postadmission, survivors were invited to a systematic clinical follow-up. Of 131 participants, 110 attended the follow-up clinic. Most (74%) had persistent symptoms (notably breathlessness and excessive fatigue) and limitations in reported physical ability. However, clinically significant abnormalities in chest radiograph, exercise tests, blood tests and spirometry were less frequent (35%), especially in patients not requiring supplementary oxygen during their acute infection (7%). Results suggest that a holistic approach focusing on rehabilitation and general well-being is paramount.